Imunon, INC Form 4 insider transactions

Christine A. Pellizzari, a director of Imunon, Inc., acquired stock options exercisable for 4,500 shares of common stock at a price of $0.86 on March 15, 2024.

Director Stacy Lindborg reports the acquisition of stock options in Imunon, Inc.

Director James E. Dentzer acquired stock options in Imunon, Inc. on March 15, 2024.